V-Wave Announces Late-Breaking Primary Results from Pivotal, Double-Blind, Randomized ...

Retrieved on: 2024-04-06 19:58:17

Tags for this article:

Heart diseases

Cardiomyopathy

Heart failure with preserved ejection fraction

Diabetic cardiomyopathy

Sacubitril/valsartan

V-Wave Inc.

United States

Click the tags to see associated articles and topics

V-Wave Announces Late-Breaking Primary Results from Pivotal, Double-Blind, Randomized .... View article details on HISWAI: https://www.prnewswire.com/news-releases/v-wave-announces-late-breaking-primary-results-from-pivotal-double-blind-randomized-controlled-relieve-hf-trial-of-the-ventura-interatrial-shunt-showing-reduced-clinical-events-in-advanced-heart-failure-patients-with-reduced-l-302109748.html

Excerpt

AGOURA HILLS, Calif., April 6, 2024 /PRNewswire/ -- V-Wave Inc., a privately held medical device company, today announced primary results from the ...

Article found on: www.prnewswire.com

View Original Article